Exchange: NASDAQ·Updated 07:30 PM EDT
ABVX logo

ABVX Abivax - ADR

$115.19
$2.96
(2.66%)
Today
Closed $114.04
$1.16
(1.01%)
After Hours
EarningsSep 21
Mkt Cap$9.95B
Vol1.11M

About ABVX

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.
45

Neutral Sentiment

How do you feel about ABVX?

Advertisement|Remove ads.